Another reversal for the AIDS Vaccine Trial?
D016915:AIDS Vaccines; D002986:Clinical Trials as Topic; D005380:Financing, Government; D015686:Gene Products, env / Q000276:immunology; D006077:Government Agencies; D019302:HIV Envelope Protein gp160; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D011498:Protein Precursors / Q000276:immunology; D011994:Recombinant Proteins; D014481:United States; D014483:United States Dept. of Health and Human Services; D014614:Vaccines, Synthetic
D016915:AIDS Vaccines; D015686:Gene Products, env; D019302:HIV Envelope Protein gp160; D011498:Protein Precursors; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; C053473:VaxSyn HIV-1 (gp160) vaccine